Literature DB >> 18392341

High factor VIIa levels do not promote tumor metastasis.

Lois W Brüggemann, Henri H Versteeg, Pieter H Reitsma, C Arnold Spek.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18392341     DOI: 10.1160/TH07-11-0702

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  5 in total

1.  Endogenous activated protein C is essential for immune-mediated cancer cell elimination from the circulation.

Authors:  G L van Sluis; L W Brüggemann; C T Esmon; P W Kamphuisen; D J Richel; H R Büller; C J F van Noorden; C A Spek
Journal:  Cancer Lett       Date:  2011-03-21       Impact factor: 8.679

2.  A low molecular weight heparin inhibits experimental metastasis in mice independently of the endothelial glycocalyx.

Authors:  Geerte L Van Sluis; Max Nieuwdorp; Pieter W Kamphuisen; Johan van der Vlag; Cornelis J F Van Noorden; C Arnold Spek
Journal:  PLoS One       Date:  2010-06-21       Impact factor: 3.240

3.  Endogenous activated protein C limits cancer cell extravasation through sphingosine-1-phosphate receptor 1-mediated vascular endothelial barrier enhancement.

Authors:  Geerte L Van Sluis; Tatjana M H Niers; Charles T Esmon; Wikky Tigchelaar; Dick J Richel; Harry R Buller; Cornelis J F Van Noorden; C Arnold Spek
Journal:  Blood       Date:  2009-07-01       Impact factor: 22.113

4.  Irradiated riboflavin diminishes the aggressiveness of melanoma in vitro and in vivo.

Authors:  Daisy Machado; Silvia M Shishido; Karla C S Queiroz; Diogo N Oliveira; Ana L C Faria; Rodrigo R Catharino; C Arnold Spek; Carmen V Ferreira
Journal:  PLoS One       Date:  2013-01-16       Impact factor: 3.240

5.  Experimental melanoma metastasis in lungs of mice with congenital coagulation disorders.

Authors:  Lois W Brüggemann; Henri H Versteeg; Tatjana M Niers; Pieter H Reitsma; C Arnold Spek
Journal:  J Cell Mol Med       Date:  2008-03-20       Impact factor: 5.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.